STERIS plc
STENYSEHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $22.73B
- P/E (TTM)
- 28.23
- Forward P/E
- 22.81
- Dividend yield
- 1.11%
- 52-week range
- $195.14$269.44
- Volume (live)
- -
- Avg. volume (3M)
- 700.54K
STERIS (STE) Stock Price & Financial Analysis
STERIS Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $229.39 - $233.14 |
|---|---|
| 52-Week High | $269.44 |
| 52-Week Low | $195.14 |
| Open | $230.79 |
| Volume (last close) | 564.65K |
| Average Volume (3M) | 700.54K |
| Revenue (TTM) | 6.04B |
|---|---|
| Net Income (TTM) | 805.10M |
| Free Cash Flow (TTM) | 925.60M |
| EPS (TTM) | $8.18 |
| Profit Margin | 13.33% |
| Operating Margin | 18.91% |
| Return on Equity (ROE) | 11.17% |
| Debt to Equity | 0.26 |
| Annual Dividend | $2.58 |
|---|---|
| Dividend Yield | 1.11% |
| Payout Ratio | 31.56% |
| Last Dividend Ex-Date | Sep 4, 2026 |
| Market Cap | 22.73B |
|---|---|
| Shares Outstanding | 97.90M |
| P/E Ratio (TTM) | 28.23 |
| Forward P/E | 22.81 |
| Price to Sales (P/S) | 3.76 |
| Price to Book (P/B) | 3.15 |
| EV/EBITDA | 12.88 |
| 50-Day MA | $220.76 |
|---|---|
| 200-Day MA | $225.95 |
| 1-Year Change | −3.98% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
STERIS at a Glance
As of the Oct 23, 2026 close, STERIS (STE) has a market capitalization of $22.73B. The stock trades at 28.2× trailing earnings, 22.8× forward earnings and 3.8× sales. Over the trailing twelve months it earned $805.10M on revenue of $6.04B (a 13.3% profit margin) and generated $925.60M of free cash flow. Revenue grew 8.4% year over year.
As of its latest reported balance sheet, it holds $482.30M in cash and securities against $1.89B of debt, a net debt position of $1.41B.
STERIS pays a quarterly dividend totaling $2.58 per share a year, a 1.11% yield at the Oct 23, 2026 close, with a 32% payout ratio and 20 consecutive years of dividend increases.
The share price is down 4.0% over the past year. At $232.15 (the Oct 23, 2026 close) it sits within its 52-week range of $195.14 to $269.44, above its 200-day moving average of $225.95.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About STERIS
What is the current stock price for STE?
As of the Oct 23, 2026 close, STE stock trades at $232.15. The 52-week range is $195.14–$269.44, with a day range of $229.39–$233.14.
What is the P/E ratio for STE?
As of the Oct 23, 2026 close, STERIS's trailing twelve-month (TTM) P/E ratio is 28.2, meaning investors pay $28.2 for every $1 of annual earnings. The forward P/E is 22.8, reflecting analyst expectations for future earnings. STERIS operates in the Healthcare sector.
Does STE pay dividends?
Yes, STERIS pays a 1.11% annual dividend yield as of the Oct 23, 2026 close ($2.58 per share a year). The trailing twelve-month payout ratio is 31.6%. The most recent ex-dividend date was September 4, 2026.
What do analysts recommend for STE?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for STE is Buy.
What is the market cap of STE?
As of the Oct 23, 2026 close, STERIS's market capitalization is $22.73B, classifying it as a large-cap company. STERIS operates in the Healthcare sector within the Medical Devices industry.